Date: August 28, 2025
Time: 9:00 a.m. – 12 p.m.
Location: Zoom
Quorum: Met
Call to Order: The Institutional Biosafety Committee (IBC) Chair called the meeting to order at 9:00 a.m.
Approval of Previous Minutes
Minutes from July 31, 2025, were approved as written.
Protocols Reviewed
Title: “Engineered nanoparticles as novel analgesic”
NIH Guidelines Sections III-D-4-a; III-F-1; III-F-8.
Meeting Comments: The project aims to develop engineered nanoparticles as a novel analgesic by targeting neurons and delivering genetic payloads. Their effectiveness will be evaluated both in vitro and in vivo. The project does not meet DURC/P3CO criteria, and appropriate biosafety procedures and mitigation plans are in place.
Other Business: none.
Adjourn: The meeting was adjourned at 9:21a.m.